Syndax Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$21.44(as of Jan 14, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Syndax Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$21.44
Ticker SymbolSNDX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees270
CountyUSA
Market Cap$1,779.1M
EBIDTA-306.9M
10-Day Moving Average21.00
P/E Ratio-5.96
20-Day Moving Average21.00
Forward P/E Ratio0.00
50-Day Moving Average19.23
Earnings per Share-3.60
200-Day Moving Average14.19
Profit Margin-132.36%
RSI57.22
Shares Outstanding86.9M
ATR1.06
52-Week High22.73
Volume1,288,123
52-Week Low8.58
Most Recent Support Level19.57
Book Value115.4M
Most Recent Resistance Level21.63
P/B Ratio16.09
Upper Keltner23.39
P/S Ratio16.65
Lower Keltner18.61
Debt-to-Equity Ratio23.39
Next Earnings Date03/09/2026
Cash Surplus2.6M
Next Ex-Dividend DateUnknown

Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory (R/R) acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.

Syndax Pharmaceuticals Inc In Our Stock Scanner

As of Jan 15, 2026
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.